Ascendis Pharma A/S
Records under this name other than the patents Ascendis Pharma A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 41 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,879,588 | Protein-proteophore complexes Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,098,930 | PEGylated Recombinant Human Growth Hormone Compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,960,053 | PEGylated recombinant human growth hormone compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,919,033 | Dry growth hormone composition transiently linked to a polymer carrier Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,682,395 | Dry growth hormone composition transiently linked to a polymer carrier Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,062,094 | Dipeptide-based prodrug linkers for aliphatic amine-containing drugs Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,226,457 | Dry growth hormone composition transiently linked to a polymer carrier Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,272,048 | PEGylated recombinant human growth hormone compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,561,287 | Carrier-linked treprostinil prodrugs Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,511,122 | Dry growth hormone composition transiently linked to a polymer carrier Formerly held In force · From the USPTO record | In force | From the USPTO record |